Jonathan Raa | Nurphoto | Getty Images The bitcoin exchange-traded funds launching Thursday after the SEC’s long-awaited approval come at a wide variety of price points, with signs that a fee war is already underway. The Bitwise Bitcoin ETF (BITB) has the lowest expense ratio of all the new bitcoin funds, at 0.20%. Several other …
Category Archives: Investing
SEC’s Gensler gives in to a bitcoin ETF, but the hostility is still there
Gary Gensler, chairman of the US Securities and Exchange Commission (SEC), during an interview in Washington, DC, US, on Thursday, July 27, 2023. Andrew Harrer | Bloomberg | Getty Images Securities and Exchange Commission Chair Gary Gensler’s statement on why the agency has approved the listing and trading of a group of spot bitcoin ETFs …
Continue reading “SEC’s Gensler gives in to a bitcoin ETF, but the hostility is still there”
SEC approves rule changes that pave the way for bitcoin ETFs
The U.S. Securities and Exchange Commission on Wednesday approved rule changes to allow the creation of bitcoin exchange-traded funds in the U.S., a long-awaited move that will give regular investors access to the controversial and volatile cryptocurrency. The decision will likely lead to the conversion of the Grayscale Bitcoin Trust, which holds about $29 billion …
Continue reading “SEC approves rule changes that pave the way for bitcoin ETFs”
Here’s what happens when it starts trading
Crypto investors are waiting for the Securities and Exchange Commission to approve a raft of spot bitcoin applications, likely Wednesday. With a spot bitcoin ETF now looking very real, attention is turning to the details of how it will trade, how much it will cost, how much of the runup in bitcoin is due to …
Continue reading “Here’s what happens when it starts trading”
Post-Ozempic patients may eat more calories, Deutsche Bank survey finds
A customer shops in a Kroger grocery store on July 15, 2022 in Houston, Texas. Brandon Bell | Getty Images Investors have cheered a new class of weight loss drugs for their ability to help people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face if they cease treatment. …
Continue reading “Post-Ozempic patients may eat more calories, Deutsche Bank survey finds”
Top Wall Street analysts prefer these 3 stocks for long-term growth
Workers install a Nike logo lamp outside the Wukesong Arena in Beijing, August 28, 2019. Tingshu Wang | Reuters The U.S. stock market started 2024 on a dismal note, but investors will need to look past the short-term uncertainty. Rather than worrying about the slow start to the year, investors should focus on adding stocks …
Continue reading “Top Wall Street analysts prefer these 3 stocks for long-term growth”
How ValueAct may help boost margins at this Japanese medical device company
Dobrila Vignjevic | E+ | Getty Images Company: Nihon Kohden Company: Nihon Kohden (6849.T-JP) Business: Nihon Kohden is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The company offers a wide array of devices to aid with …
Continue reading “How ValueAct may help boost margins at this Japanese medical device company”
Cliff Asness’ AQR Absolute Return fund gains 18.5% in 2023
Cliff Asness. Chris Goodney | Bloomberg | Getty Images Cliff Asness’ longest running multistrategy fund at AQR Capital Management returned 18.5% last year, net of fees, according to a person familiar with the performance. The AQR Absolute Return strategy, which was created in 1998, benefited the most from profitable picks among value stocks in 2023, according …
Continue reading “Cliff Asness’ AQR Absolute Return fund gains 18.5% in 2023”
Ken Griffin’s hedge fund Citadel posts double-digit returns in 2023, but lags the broader market
Ken Griffin, Citadel at CNBC’s Delivering Alpha, Sept. 28, 2022. Scott Mlyn | CNBC Billionaire investor Ken Griffin’s various hedge fund strategies all posted double-digit returns for 2023, but they failed to beat the broader market. Citadel’s multistrategy Wellington fund gained 15.3% last year, according to a person familiar with the returns. The flagship fund had …
Big Short’s Steve Eisman worries investors are too bullish in 2024
Investor Steve Eisman of “The Big Short” fame is questioning the level of bullishness on Wall Street — even with the market’s tepid start to the year. From enthusiasm surrounding the “Magnificent Seven” technology stocks to expectations for multiple interest rate cuts this year, Eisman believes there’s little tolerance for things going wrong. “Long term, …
Continue reading “Big Short’s Steve Eisman worries investors are too bullish in 2024”